K KNACK PHARMACEUTICALS YOUR HEALTH PARTNER
Dead / Abandoned — Abandoned — failure to respond (as of 03 Nov 2022)
What this means for you
This application is over — abandoned 24 Oct 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87818001
- Mark type
- Design + words
- Filed
- 02 Mar 2018
- Published for opposition
- 24 Jul 2018
- Abandoned
- 24 Oct 2022
- Attorney of record
- Tomas Maria Casalins
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of epilepsy disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of skin diseases, allergies and rheumatic disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of Alzheimer; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of ophthalmic related disorders and diseases; Pharmaceutical preparations for the treatment and prevention of musculoskeletal related diseases and disorders; Pharmaceutical preparations for the support and promotion of bone strength and health; Pharmaceutical preparations for the treatment of bone disorders and bone diseases; Pharmaceutical preparations for the treatment of toxic effects; Pharmaceutical preparations for use as injectable anesthetics; Pharmaceutical preparations for use as contraceptives; Pharmaceutical preparations for fertility enhancement purposes; Pharmaceutical preparations for use in hormone replacement therapy; Pharmaceutical preparations for the prevention and treatment of hormone disorders and deficiencies; Pharmaceutical preparations for inducing labor and facilitating nursing; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the treatment and prevention of metabolic, endocrine and kidney related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of nausea and vomiting; Pharmaceutical preparations for the prevention and treatment of aids-related disorders and diseases; Pharmaceutical preparations for treatment and prevention of viral and bacterial infections; Pharmaceutical preparations, namely, injectable contraceptives
Owner
- KNACK PHARMACEUTICALS, INC., New York City, NY, US
- KNACK PHARMACEUTICALS, INC., New York City, NY, US
Prosecution history
- 04 Nov 2022 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 03 Nov 2022 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 03 Nov 2022 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 21 Apr 2022 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 21 Apr 2022 — FINAL REFUSAL E-MAILED
- 21 Apr 2022 — SU - FINAL REFUSAL - WRITTEN
- 28 Mar 2022 — ASSIGNED TO EXAMINER
- 23 Mar 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 23 Mar 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 Mar 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 16 Mar 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 17 Nov 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Nov 2021 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 17 Nov 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 17 Nov 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED